2 stocks I’d buy after FY results

Check out these two hot stocks which have just reported impressive results.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

March is a busy month for company results, and that gives us a chance to examine some that we might normally pass over. Here are two that look potentially exciting to me.

An undervalued small cap?

Charles Taylor Consulting (LSE: CTR) is a smaller company that I’ve liked the look of for a while. Charles Taylor provides professional services to the insurance industry, which is looking healthier now than it’s been for some years, and I reckon that should lead the way to nice profits for related service firms.

After a few tough years when the sector was in a slump, Charles Taylor has been rebounding nicely, with EPS growth of 40% reported in 2015. And it’s just reported a further rise of 11.5% for the year ended December 2016, after revenue rose by 18.1% to £169.3m and adjusted pre-tax profit gained 4% to £14.8m. Debt was up to £37.5m, though the firm described that as a return to “normal levels“.

The dividend was lifted by 5% to 10.5p, with further inflation-busting increases already forecast for this year and next, which would push the yield to 4.5% and more.

Chief executive David Marock said the firm is reinvesting to drive growth “both organically and by undertaking strategic acquisitions, entering into joint ventures and making business investments” and is looking to “create opportunities to drive future growth in the medium to longer term“.

What I’m seeing here is a company looking forward to a decent growth phase and valued quite modestly for that on a forward P/E of 11, dropping to 10.4 on 2018 forecasts. On top of that, we also have a firm that is strong on cash generation and able to offer progressive and well-covered dividends. Looks like a winner to me.

Gambling growth

In 32Red (LSE: TTR) I see a stock that would have greatly excited a younger me, back when growth investing was my thing. I’m seeing a young-ish company in a relatively new market, whose earnings have really started to take off and whose shares are still priced attractively on classic growth metrics.

Results have just been released for what the firm called “a record year for revenue and profit” in 2016, with net gaming revenue up 28% to £62.3m and EBITDA more than doubling to £10.6m. Diluted earnings per share soared to 6.93p and the dividend was hiked by 89% to 5.3p per share.

Still in its early days, the worldwide online gambling business is still feeling its way forward regarding regulation and taxation, and that’s something that has given a few firms the occasional setback. But 32Red says that 77% of its net gaming revenues now come from regulated and taxed markets, and that seems to represent a maturing of the business and a reduction of risk.

What’s the growth valuation looking like now? EPS growth looks set to slow a little, which is to be expected, but with 20% on the cards we’d still see a forward PEG of 0.7 for this year — and it would fall to 0.6 a year later with another 18% earnings rise penciled in.

There’s always the same big risk with shares like this — the first time results come in slightly behind expectations, we usually see a desertion by early investors and a share price drop.  But with two years of attractive PEG valuations in the pipeline, growth investors would do well to look beyond that.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »